How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

SC

LSE:Scancell Holdings
Get a brief AI stock analysisSaves ~ 15 minutes of your time

SC

Scancell Holdings PLCLSE Scancell Holdings Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XLON - London Stock Exchange

FAIR VALUE

Is SCLP undervalued compared to its fair value?

The fair value of SCLP stock is hidden GBX. Relative to the market price of 13 GBX Scancell Holdings PLC is hidden.

Scancell Holdings Plc engages in the development of novel therapeutic vaccines for the treatment of cancer. The company is headquartered in Oxford, Oxfordshire and currently employs 40 full-time employees. The company we...[More about valuation]

Scancell Holdings PLC Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.144 $B

Price:

13 GBX

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.003

FINANCIALS

Scancell Holdings PLC financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0081 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0025 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.022 B
-0.0084 B

Financial Position Analysis

Assets

0.022 B
Current Assets
0.017 B
Total non-current assets
0.0052 B

Total current liabilities
0.002 B
Total non-current liabilities
0.029 B

Cash Flow Statement

-0.007 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0068 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Scancell Holdings PLC fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is SCLP attractive for investment based on fundamental analysis?

SCLP stock rating is hidden. Scancell Holdings PLC is a hidden by Eyestock methodology.

Get SCLP Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

SCLP.L analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for SCLP.L to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Scancell Holdings PLC competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Scancell Holdings PLC dividends

SCLP.L dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About SCLP.L stock

About the company Scancell Holdings PLC

Market cap $B

0.144

Dividend yield

Shares outstanding

818.403 B

Scancell Holdings Plc engages in the development of novel therapeutic vaccines for the treatment of cancer. The company is headquartered in Oxford, Oxfordshire and currently employs 40 full-time employees. The company went IPO on 2010-07-30. The firm is focused on developing immunotherapies for the treatment of cancer and infectious disease. Its technology includes ImmunoBody, GlyMab, Moditope, and AvidiMab. Its products pipeline include SCIB1 & iSCIB1+, SCIB2 & iSCIB2, Modi-1, Modi-2, and SCOV1 and SCOV2 (COVIDITY), as well as Anti-glycan antibodies. Its SCIB1, is developed for the treatment of patients with metastatic melanoma. SCIB1 consists of SCIB1-001 and SCIB1-002. Its SCIB2 is the second cancer vaccine based on the ImmunoBody technology. The SCIB2 & iSCIB2 vaccine is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer. Modi-1 is based on Moditope platform, which is composed of a combination of three peptides from two target antigens that are commonly modified in cancer cells. Modi-2 targets homocitrullinated cancer antigens, to address different cancer indications to Modi-1, including tumors.

SCLP.L profile

  • Ticker

    SCLP.L

  • Country

    Great Britain

  • Exchange

    XLON - London Stock Exchange

  • Report currency

    GBP - British pound

  • IPO date

    30 July 2010

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    40

  • City

    Oxford

  • Address

    John Eccles House, Oxford Science Park, Robert Robinson Avenue

  • Cusip

    G7856P123